328 related articles for article (PubMed ID: 23994040)
41. TLR3 and TLR4 SNP variants in the liver disease resulting from hepatitis B virus and hepatitis C virus infection.
Sghaier I; Zidi S; Mouelhi L; Ghazoueni E; Brochot E; Almawi WY; Loueslati BY
Br J Biomed Sci; 2019 Jan; 76(1):35-41. PubMed ID: 30421643
[TBL] [Abstract][Full Text] [Related]
42. Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma.
Chan HL; Hui AY; Wong ML; Tse AM; Hung LC; Wong VW; Sung JJ
Gut; 2004 Oct; 53(10):1494-8. PubMed ID: 15361502
[TBL] [Abstract][Full Text] [Related]
43. Hepatitis B: liver fibrosis and hepatocellular carcinoma.
Lok AS
Gastroenterol Clin Biol; 2009; 33(10-11):911-5. PubMed ID: 19577871
[TBL] [Abstract][Full Text] [Related]
44. Non-sequencing molecular approaches to identify preS2-defective hepatitis B virus variants proved to be associated with severe liver diseases.
Raimondo G; Costantino L; Caccamo G; Pollicino T; Squadrito G; Cacciola I; Brancatelli S
J Hepatol; 2004 Mar; 40(3):515-9. PubMed ID: 15123368
[TBL] [Abstract][Full Text] [Related]
45. Hepatitis B virus-induced hepatocellular carcinoma: functional roles of MICA variants.
Tong HV; Toan NL; Song LH; Bock CT; Kremsner PG; Velavan TP
J Viral Hepat; 2013 Oct; 20(10):687-98. PubMed ID: 24010643
[TBL] [Abstract][Full Text] [Related]
46. Preponderance of hepatitis B virus genotype B contributes to a better prognosis of chronic HBV infection in Okinawa, Japan.
Sakugawa H; Nakasone H; Nakayoshi T; Orito E; Mizokami M; Yamashiro T; Maeshiro T; Kinjo F; Saito A; Miyagi Y
J Med Virol; 2002 Aug; 67(4):484-9. PubMed ID: 12115993
[TBL] [Abstract][Full Text] [Related]
47. Influence of viral load and genotype in the progression of Hepatitis B-associated liver cirrhosis to hepatocellular carcinoma.
Mahmood S; Niiyama G; Kamei A; Izumi A; Nakata K; Ikeda H; Suehiro M; Kawanaka M; Togawa K; Yamada G
Liver Int; 2005 Apr; 25(2):220-5. PubMed ID: 15780042
[TBL] [Abstract][Full Text] [Related]
48. Clinicopathological differences between hepatitis B viral genotype B- and C-related resectable hepatocellular carcinoma.
Lin CL; Chen JD; Liu CJ; Lee PH; Chen PJ; Lai MY; Kao JH; Chen DS
J Viral Hepat; 2007 Jan; 14(1):64-9. PubMed ID: 17212646
[TBL] [Abstract][Full Text] [Related]
49. HLA-DP polymorphisms affect the outcomes of chronic hepatitis B virus infections, possibly through interacting with viral mutations.
Zhang Q; Yin J; Zhang Y; Deng Y; Ji X; Du Y; Pu R; Han Y; Zhao J; Han X; Zhang H; Cao G
J Virol; 2013 Nov; 87(22):12176-86. PubMed ID: 24006435
[TBL] [Abstract][Full Text] [Related]
50. Hepatocellular carcinoma and hepatitis B virus.
Chan HL; Sung JJ
Semin Liver Dis; 2006 May; 26(2):153-61. PubMed ID: 16673293
[TBL] [Abstract][Full Text] [Related]
51. Role of single nucleotide polymorphisms of KIF1B gene in HBV-associated viral hepatitis.
Al-Qahtani A; Al-Anazi M; Viswan NA; Khalaf N; Abdo AA; Sanai FM; Al-Ashgar H; Al-Ahdal M
PLoS One; 2012; 7(9):e45128. PubMed ID: 23028799
[TBL] [Abstract][Full Text] [Related]
52. Impact of the hepatitis B virus genotype and genotype mixtures on the course of liver disease in Vietnam.
Toan NL; Song le H; Kremsner PG; Duy DN; Binh VQ; Koeberlein B; Kaiser S; Kandolf R; Torresi J; Bock CT
Hepatology; 2006 Jun; 43(6):1375-84. PubMed ID: 16729315
[TBL] [Abstract][Full Text] [Related]
53. Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients.
Squadrito G; Pollicino T; Cacciola I; Caccamo G; Villari D; La Masa T; Restuccia T; Cucinotta E; Scisca C; Magazzu D; Raimondo G
Cancer; 2006 Mar; 106(6):1326-30. PubMed ID: 16453330
[TBL] [Abstract][Full Text] [Related]
54. Nucleotide change of codon 38 in the X gene of hepatitis B virus genotype C is associated with an increased risk of hepatocellular carcinoma.
Muroyama R; Kato N; Yoshida H; Otsuka M; Moriyama M; Wang Y; Shao RX; Dharel N; Tanaka Y; Ohta M; Tateishi R; Shiina S; Tatsukawa M; Fukai K; Imazeki F; Yokosuka O; Shiratori Y; Omata M
J Hepatol; 2006 Dec; 45(6):805-12. PubMed ID: 17050029
[TBL] [Abstract][Full Text] [Related]
55. [Relationship between mutation on precore region of integrated HBV DNA and p53 gene mutation in hepatocellular carcinoma].
Wang XH; Wang PL
Ai Zheng; 2003 Jul; 22(7):715-8. PubMed ID: 12866962
[TBL] [Abstract][Full Text] [Related]
56. Association between hypoxia-inducible factor-1α gene polymorphisms and risk of chronic hepatitis B and hepatitis B virus-related liver cirrhosis in a Chinese population: a retrospective case-control study.
Lu Y; Sui J; Liu Y; Li R; Ma L; Zhang X; Qin X; Li S
Gene; 2015 Jun; 564(1):96-100. PubMed ID: 25824382
[TBL] [Abstract][Full Text] [Related]
57. [Risk features of HBV in human hepatocarcinogenesis: a nested case-controlled study].
Zhang F; Shao YF; Gao JD; Xu Y; Liu GT; Xu LB; Wu ZY; Gao WH; Sun ZT
Zhonghua Wai Ke Za Zhi; 2007 Nov; 45(21):1482-4. PubMed ID: 18275715
[TBL] [Abstract][Full Text] [Related]
58. Direct effects of hepatitis B virus-encoded proteins and chronic infection in liver cancer development.
Ringelhan M; Heikenwalder M; Protzer U
Dig Dis; 2013; 31(1):138-51. PubMed ID: 23797136
[TBL] [Abstract][Full Text] [Related]
59. Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia.
Elkady A; Tanaka Y; Kurbanov F; Oynsuren T; Mizokami M
J Gastroenterol Hepatol; 2008 Mar; 23(3):474-81. PubMed ID: 18318825
[TBL] [Abstract][Full Text] [Related]
60. Association of Single Nucleotide Polymorphism rs1053004 in Signal Transducer and Activator of Transcription 3 (STAT3) with Susceptibility to Hepatocellular Carcinoma in Thai Patients with Chronic Hepatitis B.
Chanthra N; Payungporn S; Chuaypen N; Pinjaroen N; Poovorawan Y; Tangkijvanich P
Asian Pac J Cancer Prev; 2015; 16(12):5069-73. PubMed ID: 26163643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
